Cullin1 binds and promotes NLRP3 ubiquitination to repress systematic inflammasome activation

Activation of the NACHT, leucine‐rich repeat, and pyrin domains‐containing protein 3 (collectively known as NLRP3) inflammasome plays a key role in host immune response, which is the first line of defense against cellular stresses and pathogen infections. However, excessive inflammasome activation damages host cells, and therefore it must be precisely controlled. Here, we discover that Cullin1 (CUL1), a key component of the Skp1‐Cullin1‐F‐box E3 ligase, plays a critical role in controlling the NLRP3 inflammasome. CUL1 represses inflammasome assembly in cultured cells, suppresses NLRP3 function in human monocytic cell line macrophages, and attenuates inflammatory responses in mouse model. Detailed studies demonstrate that CUL1 interacts with NLRP3 and promotes NLRP3 ubiquitination, but not protein degradation, to repress the NLRP3 inflammasome activation. Moreover, upon inflammatory stimuli, including ATP and nigericin treatments, CUL1 disassociates from NLRP3 to release the repression of the NLRP3 inflammasome. Thus, this study reveals a distinct and unique mechanism underlying the control of systematic activation of the NLRP3 inflammasome.—Wan, P., Zhang, Q., Liu, W., Jia, Y., Ai, S., Wang, T., Wang, W., Pan, P., Yang, G., Xiang, Q., Huang, S., Yang, Q., Zhang, W., Liu, F., Tan, Q., Zhang, W., Wu, K., Liu, Y., Wu, J. Cullin1 binds and promotes NLRP3 ubiquitination to repress systematic inflammasome activation. FASEB J. 33, 5793–5807 (2019). www.fasebj.org

[1]  G. López-Castejón.  Control of the inflammasome by the ubiquitin system , 2019, The FEBS journal.

[2]  Nobuhiro Nakamura,et al.  Ubiquitin System , 2018, International journal of molecular sciences.

[3]  F. Liu,et al.  Zika virus infection induces host inflammatory responses by facilitating NLRP3 inflammasome assembly and interleukin-1β secretion , 2018, Nature Communications.

[4]  Ryouta Kamata,et al.  ARIH2 Ubiquitinates NLRP3 and Negatively Regulates NLRP3 Inflammasome Activation in Macrophages , 2017, The Journal of Immunology.

[5]  Jing Zhao,et al.  The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3 , 2016, Nature Communications.

[6]  T. Ichinohe,et al.  The RNA- and TRIM25-Binding Domains of Influenza Virus NS1 Protein Are Essential for Suppression of NLRP3 Inflammasome-Mediated Interleukin-1β Secretion , 2016, Journal of Virology.

[7]  A. Rösen‐Wolff,et al.  Caspase-1: an integral regulator of innate immunity , 2015, Seminars in Immunopathology.

[8]  Bill B. Chen,et al.  Lipopolysaccharide Primes the NALP3 Inflammasome by Inhibiting Its Ubiquitination and Degradation Mediated by the SCFFBXL2 E3 Ligase* , 2015, The Journal of Biological Chemistry.

[9]  F. Sutterwala,et al.  Initiation and perpetuation of NLRP3 inflammasome activation and assembly , 2015, Immunological reviews.

[10]  Sung Goo Park,et al.  Small heterodimer partner interacts with NLRP3 and negatively regulates activation of the NLRP3 inflammasome , 2015, Nature Communications.

[11]  Lei Liu,et al.  Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome , 2015, Cell.

[12]  D. Broadhurst,et al.  Rapid inflammasome activation in microglia contributes to brain disease in HIV/AIDS , 2014, Retrovirology.

[13]  E. Alnemri,et al.  The Mitochondrial Antiviral Protein MAVS Associates with NLRP3 and Regulates Its Inflammasome Activity , 2013, The Journal of Immunology.

[14]  E. Latz,et al.  Activation and regulation of the inflammasomes , 2013, Nature Reviews Immunology.

[15]  R. Germain,et al.  The Adaptor MAVS Promotes NLRP3 Mitochondrial Localization and Inflammasome Activation , 2013, Cell.

[16]  John Calvin Reed,et al.  The CARD plays a critical role in ASC foci formation and inflammasome signalling. , 2013, The Biochemical journal.

[17]  Junying Yuan,et al.  Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. , 2013, Molecular cell.

[18]  P. Vajjhala,et al.  Multiple Binding Sites on the Pyrin Domain of ASC Protein Allow Self-association and Interaction with NLRP3 Protein* , 2012, The Journal of Biological Chemistry.

[19]  M. Summers,et al.  Skp1-Cul1-F-box Ubiquitin Ligase (SCFβTrCP)-mediated Destruction of the Ubiquitin-specific Protease USP37 during G2-phase Promotes Mitotic Entry* , 2012, The Journal of Biological Chemistry.

[20]  E. Alnemri,et al.  Non-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation* , 2012, The Journal of Biological Chemistry.

[21]  K. Fitzgerald,et al.  Regulation of inflammasome signaling , 2012, Nature Immunology.

[22]  Richard A. Flavell,et al.  Inflammasomes in health and disease , 2012, Nature.

[23]  F. Sutterwala,et al.  Sensing damage by the NLRP3 inflammasome , 2011, Immunological reviews.

[24]  Thomas Hartmann,et al.  The cullin protein family , 2011, Genome Biology.

[25]  Pedro Romero,et al.  Type I interferon inhibits interleukin-1 production and inflammasome activation. , 2011, Immunity.

[26]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[27]  J. Tschopp,et al.  NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? , 2010, Nature Reviews Immunology.

[28]  V. Vacic,et al.  Identification, analysis, and prediction of protein ubiquitination sites , 2010, Proteins.

[29]  E. Latz.  The inflammasomes: mechanisms of activation and function. , 2010, Current opinion in immunology.

[30]  D. Finley,et al.  Recognition and processing of ubiquitin-protein conjugates by the proteasome. , 2009, Annual review of biochemistry.

[31]  R. Deshaies,et al.  RING domain E3 ubiquitin ligases. , 2009, Annual review of biochemistry.

[32]  F. Martinon,et al.  The inflammasomes: guardians of the body. , 2009, Annual review of immunology.

[33]  B. Clurman,et al.  FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation , 2008, Nature Reviews Cancer.

[34]  E. Alnemri,et al.  The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation , 2007, Cell Death and Differentiation.

[35]  Yi Sun.  E3 ubiquitin ligases as cancer targets and biomarkers. , 2006, Neoplasia.

[36]  Michael Karin,et al.  Intracellular pattern recognition receptors in the host response , 2006, Nature.

[37]  J. Bertin,et al.  Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. , 2006, Immunity.

[38]  A. Ciechanover,et al.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. , 2002, Physiological reviews.

[39]  J. Arbeit,et al.  Loss of Cul1 results in early embryonic lethality and dysregulation of cyclin E , 1999, Nature Genetics.

[40]  Mike Tyers,et al.  F-Box Proteins Are Receptors that Recruit Phosphorylated Substrates to the SCF Ubiquitin-Ligase Complex , 1997, Cell.

[41]  K. O. Elliston,et al.  A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes , 1992, Nature.

[42]  J. Tschopp,et al.  The Inflammasomes , 2010, Cell.

[43]  Raymond J. Deshaies,et al.  Function and regulation of cullin–RING ubiquitin ligases , 2005, Nature Reviews Molecular Cell Biology.

[44]  J. Tschopp,et al.  The inflammasome , 2005, Current Biology.